Based on Syn(+) or CgA(+) staining, six stage III patients were diagnosed as neuroendocrine tumor/neuroendocrine carcinoma (NET/NEC) or mixed adenoneuroendocrine carcinoma (MANEC) according to the 2010 World Health Organization (WHO) classification. This evidence concerns the gene CGA and neuroendocrine carcinoma.